Anacor Pharmaceuticals And Sandoz Enter Into An Agreement For The Commercialization Of KERYDIN In The United States
July 21, 2014 at 07:03 AM EDT
Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced that it has entered into an exclusive agreement with Sandoz Inc., a Novartis ...
